info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143636 |
| CAS No | NA |
| Mol.F. | C5D12N2O |
| Mol.Wt. | 128.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143637 |
| CAS No | NA |
| Mol.F. | C6H2D4F3N5O |
| Mol.Wt. | 225.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143638 |
| CAS No | NA |
| Mol.F. | C13H18N4O5S |
| Mol.Wt. | 342.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143639 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143640 |
| CAS No | NA |
| Mol.F. | C7H12N2O5 |
| Mol.Wt. | 204.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-N0143641 |
| CAS No | NA |
| Mol.F. | C11H21N3O5 |
| Mol.Wt. | 275.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143642 |
| CAS No | NA |
| Mol.F. | C24H27F3N4O4 |
| Mol.Wt. | 492.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143643 |
| CAS No | NA |
| Mol.F. | C11H14N4O2 |
| Mol.Wt. | 234.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143644 |
| CAS No | NA |
| Mol.F. | C18H15F3N4O3 |
| Mol.Wt. | 392.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143645 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 192.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143646 |
| CAS No | NA |
| Mol.F. | C27H29N5O2 |
| Mol.Wt. | 455.56 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143647 |
| CAS No | NA |
| Mol.F. | C2729N5O3 |
| Mol.Wt. | 471.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143648 |
| CAS No | NA |
| Mol.F. | C14H19N5O2 |
| Mol.Wt. | 289.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143649 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 547 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143650 |
| CAS No | NA |
| Mol.F. | C9H11N7OS |
| Mol.Wt. | 265.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143651 |
| CAS No | NA |
| Mol.F. | C5H9N3O2 |
| Mol.Wt. | 143.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
